Cancer systems biology and modeling: Microscopic scale and multiscale approaches

Seminars in Cancer Biology

Volumn 30, Issue , 2015, Pages 60-69

  Masoudi Nejad, Ali ^a   Bidkhori, Gholamreza ^a   Hosseini Ashtiani, Saman ^a   Najafi, Ali ^a   Bozorgmehr, Joseph H ^a   Wang, Edwin ^b,c  

^a UNIVERSITY OF TEHRAN   (Iran)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer; Cell proliferation and survival; Multiscale modeling; Systems biology

Indexed keywords

ALGORITHM; ANGIOGENESIS; BOOLEAN NETWORK; CANCER GROWTH; CANCER MODELING; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR AUTOMATA; EPIGENETICS; GENETICS; HIGH THROUGHPUT SCREENING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL MODEL; MICROSCOPY; MULTI AGENT SYSTEMS; MULTISCALE MODELING; NONHUMAN; PETRI NETS; REVIEW; SIMULATION; STOCHASTIC MODEL; SYSTEMS BIOLOGY; NEOPLASM; THEORETICAL MODEL;

HUMANS; MODELS, THEORETICAL; NEOPLASMS; SYSTEMS BIOLOGY;

EID: 84919652586     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2014.03.003     Document Type: Review

References (81)

1. Martins M.L., Ferreira S.C., Vilela M.J. Multiscale models for the growth of avascular tumors. Phys Life Rev 2007, 4:128-156.
2. Gibbs J.B. Mechanism-based target identification and drug discovery in cancer research. Science 2000, 287:1969-1973.
3. Friedman N., Linial M., Nachman I., Pe'er D. Using Bayesian networks to analyze expression data. J Comput Biol 2000, 7:601-620.
4. Neves S.R., Iyengar R. Modeling of signaling networks. Bioessays 2002, 24:1110-1117.
5. Papin J.A., Hunter T., Palsson B.O., Subramaniam S. Reconstruction of cellular signalling networks and analysis of their properties. Nat Rev Mol Cell Biol Bull 2005, 6:99-111.
6. Tashkova K., Korosec P., Silc J., Todorovski L., Dzeroski S. Parameter estimation with bio-inspired meta-heuristic optimization: modeling the dynamics of endocytosis. BMC Syst Biol 2011, 5:159.
7. Wang E., Zou J., Zaman N., Beitel L.K., Trifiro M., Paliouras M. Cancer systems biology in the genome sequencing era: Part 1. Dissecting and modeling of tumor clones and their networks. Semin Cancer Biol 2013, 23:279-285.
8. Sundaramurthy P., Gakkhar S. Dynamic modeling and simulation of JNK and P38 kinase cascades with feedbacks and crosstalks. IEEE Trans Nanobiosci 2010, 9:225-231.
9. Guerriero M.L., Heath J.K. Computational modeling of biological pathways by executable biology. Methods Enzymol 2011, 487:217-251.
10. Noble D. The rise of computational biology. Nat Rev Mol Cell Biol 2002, 3:459-463.
11. Kreeger P.K., Lauffenburger D.A. Cancer systems biology: a network modeling perspective. Carcinogenesis 2010, 31:2-8.
12. Reddy V.N., Liebman M.N., Mavrovouniotis M.L. Qualitative analysis of biochemical reaction systems. Comput Biol Med 1996, 26:9-24.
13. Genrich H., Küffner R., Voss K. Executable Petri net models for the analysis of metabolic pathways. J Softw Tools Technol Transfer 2001, 3:394-404.
14. Voss K., Heiner M., Koch I. Steady state analysis of metabolic pathways using Petri nets. In Silico Biol 2003, 3:367-387.
15. Koch I., Junker B.H., Heiner J.M. Application of Petri net theory for modelling and validation of the sucrose breakdown pathway in the potato tuber. Bioinformatics 2005, 21:1219-1226.
16. Sackmann A., Heiner M., Koch I. Application of Petri net based analysis techniques to signal transduction pathways. BMC Bioinformatics 2006, 7:482.
17. Grunwald S., Speer A., Ackermann J., Koch I. Petri net modelling of gene regulation of the Duchenne muscular dystrophy. Biosystems 2008, 92:189-205.
18. Koch I. Petri nets and GRN models. Handbook of research on computational methodologies in gene regulatory networks 2010, 604-637. Hershey, NY. S. Caragea Das, S.D. Welch, W.H. Hsu (Eds.).
19. Popova-Zeugmann L., Koch M.H.I. Time Petri nets for modeling and analysis of biochemical networks. Fundam Inform 2005, 67:149-162.
20. Windhager L., Erhard F., Zimmer R. Fuzzy modeling. Modeling in systems biology: the Petri net approach 2011, 179-205. Springer, Berlin, Heidelberg. I. Koch, W. Reisig, F. Schreiber (Eds.).
21. Peccoud P.J.E.G.J. Quantitative modeling of stochastic systems in molecular biology by using stochastic Petri nets. Proc Natl Acad Sci U S A 1998, 95:6750-6755.
22. Bahi-Jaber N., Pontier D. Modeling transmission of directly transmitted infectious diseases using colored stochastic Petri nets. Math Biosci 2003, 185:1-13.
23. Mura I. Stochastic modeling. Modeling in systems biology: the Petri net approach 2011, 121-152. Springer, Berlin, Heidelberg. I. Koch, W. Reisig, F. Schreiber (Eds.).
24. Koch I., Ackermann J. Quantitative analysis. Modeling in systems biology: the Petri net approach 2011, 153-178. Springer, Berlin, Heidelberg. I. Koch, W. Reisig, F. Schreiber (Eds.).
25. Matsuno H., Doi A., Nagasaki M., Miyano S. Hybrid Petri net representation of gene regulatory network. Pac Symp Biocomput 2000, 5:338-349.
26. Nagasaki M., Doi A., Matsuno H., Miyano S. Simulation based validation of the p53 transcriptional activity with hybrid functional Petri net. In Silico Biol 2006, 6.
27. Woolf P.J., Prudhomme W., Daheron L., Daley G.Q., Lauffenburger D.A. Bayesian analysis of signaling networks governing embryonic stem cell fate decisions. Bioinformatics 2005, 21:741-753.
28. Sachs K., Gifford D., Jaakkola T., Sorger P., Lauffenburger D.A. Bayesian network approach to cell signaling pathway modeling. Sci STKE 2002, 2002:pe38.
29. Needham C.J., Bradford J.R., Bulpitt A.J., Westhead D.R. A primer on learning in Bayesian networks for computational biology. PLoS Comput Biol 2007, 3:e129.
30. Wolfram S. A new kind of science 2002, Wolfram Media Inc., Champaign, Illinois.
31. De Boer R.J., van der Laan J.D., Hogeweg P. Randomness and pattern scale in the immune network: a cellular automaton approach. Thinking about biology, SFI studies in the science of complexity 1992, Addison-Wesley, Redwood City, CA.
32. Garis H.d. CAM-brain: ATR's billion neuron artificial brain project: a three year progress report. Proceedings of the international conference on evolutionary computation 1996, 886-891.
33. Savill N.J., Hogeweg P. Modelling morphogenesis: from single cells to crawling slugs. J Theor Biol 1997, 184:229-235.
34. Chen Q., Mynett A.E., Minns A.W. Application of cellular automata to modelling competitive growths of two underwater species Chara aspera and Potamogeton pectinatus in Lake Veluwe. Ecol Modell 2002, 147(3):253-265.
35. Kier L.B., Cheng C.K., Testa B., Carrupt P.A. A cellular automata model of enzyme kinetics. J Mol Graph 1996, 14:227-231.
36. Wishart D.S., Yang R., Arndt D., Tang P., Cruz J. Dynamic cellular automata: an alternative approach to cellular simulation. In Silico Biol 2005, 5:139-161.
37. Wooldridge M. An introduction to multiagent systems 2002, John Wiley & Sons Ltd., Chichester, England.
38. Jennings N.R. On agent-based software engineering. Artif Intell J 2000, 117:277-296.
39. Kitano H. Systems biology: a brief overview. Science 2002, 295:1662-1664.
40. Suresh Babu C.V., Joo Song E., Yoo Y.S. Modeling and simulation in signal transduction pathways: a systems biology approach. Biochimie 2006, 88:277-283.
41. Kirschner M.W. The meaning of systems biology. Cell 2005, 121:503-504.
42. Orton R.J., Sturm O.E., Vyshemirsky V., Calder M., Gilbert D.R., Kolch W. Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. Biochem J 2005, 392:249-261.
43. Carrillo M., Gongora P.A., Rosenblueth D.A. An overview of existing modeling tools making use of model checking in the analysis of biochemical networks. Front Plant Sci 2012, 3:155.
44. Bidkhori G., Moeini A., Masoudi-Nejad A. Modeling of tumor progression in NSCLC and intrinsic resistance to TKI in loss of PTEN expression. PLoS One 2012, 7:e48004.
45. Koh G., Lee D.Y. Mathematical modeling and sensitivity analysis of the integrated TNFalpha-mediated apoptotic pathway for identifying key regulators. Comput Biol Med 2011, 41:512-528.
46. Deisboeck T.S., Wang Z., Macklin P., Cristini V. Multiscale cancer modeling. Annu Rev Biomed Eng 2011, 13:127-155.
47. Becker S.A., Price N.D., Palsson B. Metabolite coupling in genome-scale metabolic networks. BMC Bioinformatics 2006, 7:111.
48. Darabos C., Di Cunto F., Tomassini M., Moore J.H., Provero P., Giacobini M. Additive functions in Boolean models of gene regulatory network modules. PLoS One 2011, 6:e25110.
49. Emmert-Streib F., Dehmer M. Networks for systems biology: conceptual connection of data and function. IET Syst Biol 2011, 5:185-207.
50. Janes K.A., Lauffenburger D.A. Models of signalling networks - what cell biologists can gain from them and give to them. J Cell Sci 2013, 126:1913-1921.
51. Wang E., Lenferink A., O'Connor-McCourt M. Cancer systems biology: exploring cancer-associated genes on cellular networks. Cell Mol Life Sci 2007, 64:1752-1762.
52. Liotta L.A., Kohn E.C. The microenvironment of the tumour-host interface. Nature 2001, 411:375-379.
53. Lowengrub J.S., Frieboes H.B., Jin F., Chuang Y.L., Li X., Macklin P., et al. Nonlinear modelling of cancer: bridging the gap between cells and tumours. Nonlinearity 2010, 23:R1-R9.
54. Athale C., Mansury Y., Deisboeck T.S. Simulating the impact of a molecular 'decision-process' on cellular phenotype and multicellular patterns in brain tumors. J Theor Biol 2005, 233:469-481.
55. Deroulers C., Aubert M., Badoual M., Grammaticos B. Modeling tumor cell migration: from microscopic to macroscopic models. Phys Rev E Stat Nonlin Soft Matter Phys 2009, 79:031917.
56. Shrestha S.M., Joldes G.R., Wittek A., Miller K. Cellular automata coupled with steady-state nutrient solution permit simulation of large-scale growth of tumours. Int J Numer Method Biomed Eng 2013, 29:542-559.
57. Wu F.T., Stefanini M.O., Mac Gabhann F., Popel A.S. Modeling of growth factor-receptor systems from molecular-level protein interaction networks to whole-body compartment models. Methods Enzymol 2009, 467:461-497.
58. Arakelyan L., Vainstein V., Agur Z. A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumor growth. Angiogenesis 2002, 5:203-214.
59. Qutub A.A., Popel A.S. A computational model of intracellular oxygen sensing by hypoxia-inducible factor HIF1 alpha. J Cell Sci 2006, 119:3467-3480.
60. Materi W., Wishart D.S. Computational systems biology in cancer: modeling methods and applications. Gene Regul Syst Biol 2007, 1:91-110.
61. Finley S.D., Dhar M., Popel A.S. Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice. Front Oncol 2013, 3:196.
62. Finley S.D., Popel A.S. Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions. J Natl Cancer Inst 2013, 105:802-811.
63. Nor J.E., Christensen J., Liu J., Peters M., Mooney D.J., Strieter R.M., et al. Up-regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 2001, 61:2183-2188.
64. Jain H.V., Nor J.E., Jackson T.L. Modeling the VEGF-Bcl-2-CXCL8 pathway in intratumoral angiogenesis. Bull Math Biol 2008, 70:89-117.
65. Riedemann J., Macaulay V.M. IGF1R signalling and its inhibition. Endocr Relat Cancer 2006, 13(Suppl. 1):S33-S43.
66. Bianconi F., Baldelli E., Ludovini V., Crino L., Flacco A., Valigi P. Computational model of EGFR and IGF1R pathways in lung cancer: a systems biology approach for translational oncology. Biotechnol Adv 2012, 30:142-153.
67. Brown K.S., Hill C.C., Calero G.A., Myers C.R., Lee K.H., Sethna J.P., et al. The statistical mechanics of complex signaling networks: nerve growth factor signaling. Phys Biol 2004, 1:184-195.
68. Orton R.J., Adriaens M.E., Gormand A., Sturm O.E., Kolch W., Gilbert D.R. Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway. BMC Syst Biol 2009, 3:100.
69. Zaman N., Li L., Jaramillo M.L., Sun Z., Tibiche C., Banville M., et al. Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets. Cell Rep 2013, 5:216-223.
70. Szabo A., Merks R.M. Cellular Potts modeling of tumor growth, tumor invasion, and tumor evolution. Front Oncol 2013, 3:87.
71. Guiot C., Degiorgis P.G., Delsanto P.P., Gabriele P., Deisboeck T.S. Does tumor growth follow a "universal law"?. J Theor Biol 2003, 225:147-151.
72. Delsanto P.P., Condat C.A., Pugno N., Gliozzi A.S., Griffa M. A multilevel approach to cancer growth modeling. J Theor Biol 2008, 250:16-24.
73. Ferreira S.C., Martins M.L., Vilela M.J. Reaction-diffusion model for the growth of avascular tumor. Phys Rev E Stat Nonlin Soft Matter Phys 2002, 65:021907.
74. Frieboes H.B., Smith B.R., Chuang Y.L., Ito K., Roettgers A.M., Gambhir S.S., et al. An integrated computational/experimental model of lymphoma growth. PLoS Comput Biol 2013, 9:e1003008.
75. Wang J., Zhang L., Jing C., Ye G., Wu H., Miao H., et al. Multi-scale agent-based modeling on melanoma and its related angiogenesis analysis. Theor Biol Med Model 2013, 10:41.
76. Daub J.T., Merks R.M. A cell-based model of extracellular-matrix-guided endothelial cell migration during angiogenesis. Bull Math Biol 2013, 75:1377-1399.
77. Sun X., Zhang L., Tan H., Bao J., Strouthos C., Zhou X. Multi-scale agent-based brain cancer modeling and prediction of TKI treatment response: incorporating EGFR signaling pathway and angiogenesis. BMC Bioinformatics 2012, 13:218.
78. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
79. Galle J., Loeffler M., Drasdo D. Modeling the effect of deregulated proliferation and apoptosis on the growth dynamics of epithelial cell populations in vitro. Biophys J 2005, 88:62-75.
80. Galle J., Sittig D., Hanisch I., Wobus M., Wandel E., Loeffler M., et al. Individual cell-based models of tumor-environment interactions: multiple effects of CD97 on tumor invasion. Am J Pathol 2006, 169:1802-1811.
81. Weston A.D., Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res 2004, 3(2):179-196.